医药估值重估逻辑

资本市场那些事儿
26 Jun

为什么我会提出这个概念,因为2025,有了一些新变化,对比以往的医药行业,估值的重估,开始一步步的被证实了。一、以前为啥不值钱?——机构“不见兔子不撒鹰”只看结果,不看潜力:以前投资机构只认“快卖钱的药”(比如III期临床或上市阶段),觉得临床前或早期管线(I/II期)风险太高,10个项目可能9个失败,算不过来账。打个比方:就像种树,种子刚发芽时没人出价,等结果子了才有人买。不会算“未来的钱”:...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10